D-0444-2022 Class II Terminated

Recalled by Edge Pharma, LLC — Colchester, VT

FDA drug recall D-0444-2022 was initiated by Edge Pharma, LLC on Dec 6, 2021 and is designated Class II. Reason for recall: CGMP Deviations The recall status is terminated (terminated Jun 7, 2023). Affected quantity: 231 bottles.

Recall details

Product Type
Drugs
Report Date
Feb 2, 2022
Initiation Date
Dec 6, 2021
Termination Date
Jun 7, 2023
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
231 bottles

Product description

Lidocaine HCl/Phenylephrine HCl Nasal Solution, 4%/1%, 240 mL per bottle, Multiple Dose Container, Edge Pharma, LLC 856 Hercules Dr., Colchester, VT 05446, NDC 05446-1045-03

Reason for recall

CGMP Deviations

Distribution pattern

nationwide

Code information

07-2021-02@7 12-29-2021, 07-2021-23@4 01-19-2022, 08-2021-11@7 02-07-2022, 08-2021-23@8 02-19-2022 & 09-2021-24@10 03-23-2022

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0444-2022
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0444-2022. Report a data issue: hello@regdatalab.com.